Moving in Biological Technology

Scientists moving closer to 'artificial noses'

These days, chemical analysts are expected to track down even single molecules. To do this highly sensitive detective work, nano researchers have developed minute strings that resonate in characteristic fashion. If a molecule docks onto one of the strings, then it becomes heavier, and its oscillat...

Robots moving closer to humans

Robots today are making a considerable impact on many aspects of modern life, from industrial manufacturing to healthcare. Reaching for the human frontier, robotics is also vigorously engaged in the growing challenges of new emerging domains. Interacting, exploring, and working with humans, the ne...

Academic ADL Co-Lab moving to downtown Madison

Academic ADL Co-Lab Web site MADISON In order to surpass its original goal for life-long learning from K to gray, the Madison-based Academic Advanced Distributed Learning (ADL) Co-Laboratory has plans to move from University Research Park to the downtown area. The Academic ADL Co-Lab will ...

Tech Digest: what's moving in the Midwest

Premiering this week, WTN's Tech Digest compiles new acquisitions, product announcements, purchases and other tidbits you might be interested to know about. Online careers site moves into Montana Merge eFilm provides imaging solutions to 32 new medical customers Steam-turbine vendor for...

Tech Digest: what's moving in the Midwest

FDA approves quick-dissolving oral tablets for Parkinson's disease Fiserv forms banking deals on East Coast QRG Bioscience names UW-Milwaukee professor its scientific advisor Badger Meter partners with DCSI for meter readings FDA approves quick-dissolving oral tablets for Parkinson...

Tech Digest: what's moving in the Midwest

AT&T expands retail distribution of Internet telephone service Time Warner in Green Bay to add Superconnect software TeraMedica hires new VP as CEO goes Appleton firm to build mobile Air Force lab Engineers manipulate single electrons to make efficient computer chips UW researcher...

Tech Digest: whats moving in the Midwest

UW-Extension gets $95,000 to help small businesses TeraMedica scans new market opportunity: smaller hospitals Single gene could make deadly disease Platypus plans office move next June Ink Source now property of Nor-Cote UW students use more mobile computing Schneider buys GPS ...

Tech Digest: whats moving in the Midwest

GE Healthcare profits up 31 percent for quarter ConjuGon CEO to speak on both coasts UW center to make Canadian cancer drug Wisconsin DOA buys Seritis software for data management Schneider rolls its own employment Web site GE Healthcare profits up 31 percent for quarter GE He...

Tech Digest: whats moving in the Midwest

Milken Institute predicts moderate Wisconsin biopharmaceutical growth Exxon Mobil stations enter Fiserv network Third Wave appoints regulatory director Milken Institute predicts moderate Wisconsin biopharmaceutical growth Wisconsin is home to significant biopharmaceutical innovati...

Tech Digest: whats moving in the Midwest

Home Health United signs deal with SBC UW-Stout gets USDA grant for manufacturing training ETC announces losses for third quarter Badger Meter reports increased earnings in third quarter QRG Bioscience to move to Research Park Sensient Technologies reduces debt by $47 million ...

Tech Digest: whats moving in the Midwest (10/20/04)

HomeFree wireless monitoring to be used in Alzheimers research HomeFree Inc. , a provider of wireless sensors with its U.S. headquarters in Milwaukee, has announced that it will be involved in a study of how wireless monitoring can report on the daily home life of patients with Alzheimers disea...

Tech Digest: whats moving in the Midwest (10/27/04)

Milwaukee to get $117 million medical research facility Johnson Controls' quarterly report: $273 million profit on $6.8 billion sales Plexus' quarterly report: $37 million loss on $273 million revenues Venture Center launched in Fitchburg Doyle welcomes pharmaceutical company to Wisc...

Tech Digest: whats moving in the Midwest (11/1/04)

Wisconsin-based Analogix joins French company to provide drug purification products Business filings serves Spanish-speaking small businesses Alliant Energy announces dip in third-quarter earnings from mild weather Steinhafels furniture store selects Citrix IT tools Wisconsin-based ...

Tech Digest: whats moving in the Midwest (11/3/04)

UW grads get new job-finding site IT chief becomes marketer Rockwell reports dividend Employment expectations rise WARF to put on patent-strategy conference RoleFlow Software Targets Human Resources Efficiency UW grads get new job-finding site The Wisconsin Alumni Associati...

Tech Digest: whats moving in the Midwest (11/8/04)

SBC to cut 10,000 jobs Berbee ranks highly in Microsoft partner program Milwaukee Heart Hospital to be bought by local system Wausau police nab suspected wireless hacker SBC to cut 10,000 jobs SBC Communications , the parent company of SBC Wisconsin, will cut about 10,000 jobs b...

Symphony Corp. moving into Fitchburg Technology Campus

Custom software developer Symphony Corporation is expanding into nearly 4,000 square feet of office space in the Fitchburg Technology Campus , a few minutes south of Madison. Symphony CEO Ravi Kalla said in a press release that the space is going to be customized to make it possible to serve ...

PDI Reports 2009 Second Quarter Financial Results

...e space in our marketing services business, resulting in a one-time charge of $1.8 million, which will generate future cost reductions for the Company moving forward. As previously disclosed, we also mutually terminated our product commercialization contract. "We were also pleased to announce the app...

SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS

...een granted a GRAS (Generally Recognized As Safe) regulatory designation that allows commercialization in the U.S. and other countries. Firmenich is moving forward with pre-commercialization activities. Senomyx is on-track with development activities to support regulatory filings for S6973, a sucr...

AEterna Zentaris Partner, Keryx, Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine (KRX-0401) for the Treatment of Multiple Myeloma

...afety. Juergen Engel, Ph. D., President and Chief Executive Officer of AEterna Zentaris commented, "We are very pleased and excited about perifosine moving forward into a Phase 3 trial. This represents a major milestone in our oncology drug development strategy which could hold great promise for patients ...

Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia

...cluded in the NDA was designed and conducted under prior FDA guidance and before the new draft guidance was released. Advanced Life Sciences is moving expeditiously to develop a protocol for an additional Phase 3 trial that is designed to satisfy the FDA's request for additional efficacy information....

Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing

...mmented Joel Brooks, Chief Financial Officer. "This funding, along with the $1 million in financing secured several weeks ago, enables us to continue moving forward efficiently with our goal of filing an Investigational New Drug Application and initiating a Phase I clinical trial for SNS-01." Imp...

Neurocrine Biosciences Reports Second Quarter 2009 Results

... and within the guidance we gave at the beginning of the year," said Kevin C. Gorman, President and Chief Executive Officer. "At the same time, we are moving forward with our clinical programs, the most advanced of which is elagolix, and have just put another compound, VMAT2 inhibitor into Phase I trials. ...

BP and Verenium Announce Vercipia Biofuels to Advance the Commercialization of Cellulosic Ethanol

...nology in pre-treatment, novel enzyme development, fermentation and project development for next-generation biofuels. Through Vercipia, the Company is moving rapidly to commercialize cellulosic technology for the production of ethanol from a wide array of non-food feedstocks, including dedicated energy crop...

Sanofi-aventis Announces Second Quarter 2009 Results

...f the year, we have launched a new R&D approach to increase innovation, we have strengthened our growth platforms through acquisitions, and we are moving forward with the transformation of our company. Those achievements constitute another step toward our vision of becoming a leading diversified global ...

Kendle Appoints Stephen Cutler, PhD Senior Vice President and Chief Operating Officer

... operational excellence and strategic customer relationships across the Phase II-IV market to drive increased value for our customers and shareholders moving forward." Dr. Cutler joins Kendle following 14 years with Quintiles where he most recently was Senior Vice President, Global Project Management...

Prof. Mario Tredici Shared Views on Algae Projects with Algae Business Players at Algae World!

...that are prevalent in the industry, and provides real-world examples, and scientific data to back up his observations. The Algae industry today is moving towards multiple applications including nutraceuticals, cosmetics, animal feed, Carbon capture & recycle, and wastewater treatment while research ...

Understanding Managed Markets: Effective Market Research Structures & Activities to Maximize Payer Access & Insights

...ing: Don't Wait Until It's Too Late to Develop MM Insights : MMMR activities peak during Phase 3, though most benchmark partners are moving to push these into earlier phases. This may prove most viable for breakthrough medicines where pharmacoeconomic differences can be identified, and may...

New drugs faster from natural compounds: A UC San Diego breakthrough

...mine the chemical structure of a cyclic NRP. This is called "De Novo sequencing of NRPs." Second, the researchers created "dereplication" tools for moving the other direction: taking the chemical structures of known NRPs and other related information and determining what the data signature would look lik...

Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment for Obesity

...r moderate and transient in nature. "These findings provide us with valuable data that will inform our clinical and product development strategy moving forward," said Christian Weyer, M.D., vice president, corporate development, diabetes and obesity at Amylin Pharmaceuticals. "Our integrated neurohorm...

Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost

... A two-tiered scanning-protocol for inspecting all containers at international ports could be the most affordable approach to ensuring containers moving through the global transportation system are not carrying nuclear bombs, according to a paper being presented at a services special interest group mee...

Verenium Completes Amendment to 8% Senior Convertible Notes

...reatment, novel enzyme development, fermentation and project development for next-generation biofuels. Through a joint venture with BP, the Company is moving rapidly to commercialize its proprietary technology for the production of ethanol from a wide array of non-food feedstocks, including dedicated energy...

Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement

...ype in the body. However, because they are created from adult skin cells, not embryos, they enable patient-specific stem cells, an important factor in moving the technology toward personalized medicine. The goal of the agreement's next phase is to detect drug-induced changes in cardiomyocyte activity a...

ADVENTRX Pharmaceuticals Announces Plans for Remainder of 2009

...candidates. However, we will remain receptive to strategic and partnering options if we are presented with terms that we believe surpass the value of moving forward independently toward the NDA submission," Mr. Culley continued. About ADVENTRX Pharmaceuticals Inc. ADVENTRX Pharmaceuticals is a...

YM BIOSCIENCES' SUBSIDIARY RESOLVES PROPOSED ARBITRATION WITH ONCOSCIENCE AG

...oSciences and Oncoscience have resolved their differences amicably at a minimal cost to either party and that each are committed to cooperate fully in moving nimotuzumab forward clinically with all due deliberate speed," said David Allan, Chairman and CEO of YM BioSciences. "The late-stage European clinical...

Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide

...itutions (primary universities) using SciVal Spotlight, Elsevier's new research performance measurement tool which will be released later this summer. moving beyond the traditional method of measuring research output by journal count, the SciVal Spotlight tool is built on a more detailed model of the curren...

NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces

... the Spring of 2010, targeting high net worth individuals. The Network Agreement expands NeoStem's China-related activities, which are focused on moving forward regenerative medical therapies and medical tourism for people seeking high-quality treatments not available in their own countries. Under the...

Welcome to the Biofuel Age of Flight

...to five years." Steele commented. The Beginner's Guide to Aviation Biofuels has been published to explain some of the benefits for aviation moving to a new, cleaner, source of fuel. "In a poll within the industry, almost half of those surveyed were unsure of the difference between first and ...

Senesco Technologies, Inc. Announces the Appointment of Dr. Harlan W. Waksal, M.D. as Chairman of the Board of Directors and the Addition of Mr. Warren J. Isabelle, CFA to its Board of Directors

...unique opportunity to ask him to take on these new responsibilities as Chairman of the Board. His experience in this area will best serve our efforts moving forward. We are very pleased about his acceptance of this significant role." Dr. Waksal commented about his new responsibilities, "I am excited ...

STAAR Surgical Receives CE Mark Approval for KS-X Preloaded Hydrophobic Acrylic Lens Injector System

...r of surgeons who prefer the hydrophobic acrylic lenses for their patients. With the introduction of this product in these markets, we believe we are moving toward our goal of establishing our preloaded delivery systems as the global standard of care in all IOL lens segments," Mr. Bailey said. First...

A breakthrough toward industrial production of fluorescent nanodiamonds

... in the crystal lattice. Isolated substitutional nitrogen atoms then trap a moving vacancy during annealing to form a fluorescent NV centre. Unfortunately, th...ciency and yield of this route are low due to amorphization and the loss of moving vacancies to the surface during irradiation and annealing. A top-down pro...